Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00541606 · ClinicalTrials.gov registry record · NA
Pharmacist Assisted Medication Program Enhancing the Regulation of Diabetes
A NA study, sponsored by Lahey Clinic.
- Completed
- Registry status
- NA
- Development phase
- 285
- Enrollment target
NCT00541606: Completed NA study, sponsored by Lahey Clinic.
NCT00541606 is a NA study that has completed, run by Lahey Clinic. The registered enrollment target is 285 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (80% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00541606, a NA study, has completed, sponsored by Lahey Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 285 participants
- Enrollment target
Study Summary
The purpose of this study is to demonstrate that pharmacists working collaboratively with physicians and other providers in an ambulatory care setting can improve glucose, blood pressure, and lipid control, as well as improve quality of life, adherence to screening and general preventative measures.
Interventions
- OTHER Usual care
- OTHER Pharmacist collaboration in diabetes care
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 285 participants |
| Start Date | 2000-09 |
| Est. Completion | 2004-07 |
| Phase | NA |
What the finished NCT00541606 record still lists
NCT00541606 is an interventional study that assigns participants to a tested intervention. The registered 285 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (80% lower).
The record links to 0 conditions, and to 2 interventions - of which Usual care is the first listed.
NCT00541606 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00541606 about?
NCT00541606 is a clinical study titled "Pharmacist Assisted Medication Program Enhancing the Regulation of Diabetes". The purpose of this study is to demonstrate that pharmacists working collaboratively with physicians and other providers in an ambulatory care setting can improve glucose, blood pressure, and lipid control, as well as improve quality of life, adherence to screening and general preventative measures.
What is the current status of trial NCT00541606?
This trial is currently completed. It is a NA study. The enrollment target is 285 participants. The study started on 2000-09. Estimated completion is 2004-07.
What interventions are being tested in trial NCT00541606?
The interventions under investigation include: Usual care (OTHER), Pharmacist collaboration in diabetes care (OTHER).
Who is sponsoring clinical trial NCT00541606?
This trial is sponsored by Lahey Clinic, which has 43 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00541606's enrollment target sits among peer trials
285 377th of 2000 higher than 1,624 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03412877 · 285 participants · Phase 2
Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Neoantigens in People With Metastatic Cancer
- NCT04537936 · 285 participants · NA
Psychotherapy Intervention for Latinos With Adv Cancer
- NCT04965675 · 285 participants · Phase 3
A Study With Eptinezumab in Adolescents (12-17 Years) With Chronic Migraine
- NCT05320835 · 285 participants · NA
A Setting Focus Overdose Prevention Intervention
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia